BLR&D Research Career Scientist Award Application

BLR

基本信息

  • 批准号:
    10047693
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-10-01 至 2025-09-30
  • 项目状态:
    未结题

项目摘要

Stroke is the number one cause of disability in the US. This is a result of physical impairments as well as increased risk of dementia after stroke. High blood pressure is the top risk factor for stroke followed by diabetes. High blood pressure, diabetes and stroke are highly prevalent in our Veterans. Hypertension is the most common vascular risk factor among Veterans with stroke. Moreover, among Veterans, hypertension is the most common chronic condition, affecting more than 37% of the Veteran population. 25% of our Veterans have diabetes. Despite years of extensive research, all efforts to protect neurons from ischemic stroke injury failed. There is only one treatment for stroke and that is to open the occluded blood vessels with a clot-busting drug. There is NO treatment for dementia that develops after stroke. Reasons for this failure may be several fold: 1) researchers have used otherwise healthy and young animal models in research; 2) most studies utilized male animals; and 3) researchers have tried to salvage and repair only "neurons". It is now increasingly recognized that blood vessels of the brain are extremely critical for the acute stroke injury and chronic recovery. When blood flow to the brain is compromised, cognitive impairment ensues and recovery from stroke is impaired. Targets for new treatments may be different in females and/or diseases like diabetes and high blood pressure that are commonly found in patients with stroke or cognitive impairment. This is also quite relevant to VA mission as our female Veterans are steadily increasing among our Veterans and suffering from these diseases necessitating the VA to launch the “Women’s Health Initiative”. Dr. Ergul, a well-accomplished VA Research Career Scientist and Regents’ Professor at Augusta University, uses her uniquely combined expertise in endocrinology, physiology, pharmacology and vascular biology to address these gaps by studying the interaction of diabetes and high blood pressure with associated complications such as stroke and cognitive impairment in both sexes. She is extremely committed to improve the quality of life of our Veterans and our society, a commitment solidified by Research Career Scientist recognition in the last 5 years. Her commitment to VA and cardiovascular disease research is evidenced by 1) continuous extramural finding by National Institutes of Health, American Heart Association, American Diabetes Association, and Veterans Affairs in the last 20 years, 2) her over 150 publications (59 alone during the tenure of the RCS in the last 5 years), 3) success of renewing VA Merit Award twice during the current RCS award period, 4) receiving additional extramural funding to address complementary scientific questions, 5) her stature as a leader in the field and 6) the success of her mentoring next generation of scientists.
中风是美国第一大致残原因。这是由于身体缺陷以及 中风后患痴呆症的风险增加。高血压是中风的首要危险因素,其次是 糖尿病。高血压、糖尿病和中风在我们的退伍军人中非常普遍。高血压是 中风退伍军人中最常见的血管危险因素。此外,在退伍军人中,高血压是 最常见的慢性病,​​影响超过 37% 的退伍军人。 25% 的退伍军人 患有糖尿病。尽管经过多年的广泛研究,保护神经元免受缺血性中风损伤的所有努力 失败的。中风只有一种治疗方法,那就是用溶栓药物打开闭塞的血管 药品。中风后发生的痴呆症尚无治疗方法。造成这种失败的原因可能有几个 折叠:1)研究人员在研究中使用了其他健康且年轻的动物模型; 2)大多数研究 利用雄性动物; 3)研究人员试图仅挽救和修复“神经元”。现在越来越多 认识到大脑血管对于急性中风损伤和慢性中风损伤极为关键 恢复。当流向大脑的血液受到损害时,就会出现认知障碍并从中风中恢复 受到损害。新疗法的目标在女性和/或糖尿病和高血压等疾病中可能有所不同 中风或认知障碍患者中常见的血压。这也相当 与退伍军人事务部的使命相关,因为我们的女性退伍军人在退伍军人中稳步增加,并遭受 这些疾病迫使退伍军人管理局发起“妇女健康倡议”。 Ergul 博士,一位卓有成就的 VA 研究职业科学家和奥古斯塔大学摄政教授,利用她独特的结合 内分泌学、生理学、药理学和血管生物学方面的专业知识,通过研究来弥补这些差距 糖尿病和高血压与中风和认知等相关并发症的相互作用 两性都有损害。她非常致力于提高退伍军人和我们的生活质量 过去 5 年,研究职业科学家的认可巩固了这一承诺。她的承诺 VA 和心血管疾病研究的证据是 1) 国家连续的校外发现 健康研究所、美国心脏协会、美国糖尿病协会和退伍军人事务部 过去 20 年,2) 她发表了 150 多篇出版物(仅在过去 5 年 RCS 任期内就有 59 篇),3) 在当前 RCS 奖励期内成功续订 VA 优异奖两次,4) 获得额外奖励 用于解决补充科学问题的校外资金,5) 她作为该领域领导者的地位,以及 6) 她指导下一代科学家的成功。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADVIYE ERGUL其他文献

ADVIYE ERGUL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADVIYE ERGUL', 18)}}的其他基金

ShEEP Request for Noldus EthoVision XT System
ShEEP 请求 Noldus EthoVision XT 系统
  • 批准号:
    10534037
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10293551
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10516025
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Progressive Post Stroke Cognitive Impairment:Mechanisms & Intervention
进行性中风后认知障碍:机制
  • 批准号:
    10237897
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Progressive Post Stroke Cognitive Impairment:Mechanisms & Intervention
进行性中风后认知障碍:机制
  • 批准号:
    10468083
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Progressive Post Stroke Cognitive Impairment:Mechanisms & Intervention
进行性中风后认知障碍:机制
  • 批准号:
    10011890
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
  • 批准号:
    9429297
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
  • 批准号:
    10541346
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
  • 批准号:
    9217676
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
  • 批准号:
    8848660
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:

相似海外基金

A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了